Watch our webinar session, which was held on October 2nd, 2025 : “Maximizing the Value of Liver Biopsies for MASH Management in the Era of Novel FDA-Approved Therapies”. 

Learn how our technology addresses unmet needs in MASH patient care and how FibroSIGHT™ Plus elevates the assessment of liver fibrosis – delivering clarity, confidence and precision.